Sesen Bio's IPO

Sesen Bio raised a round of funding on February 06, 2014. Investors include Public.

Sesen Bio, formerly Eleven Biotherapeutics, is a late-stage company developing next-generation antibody-drug conjugate (ADC) therapies for patients with cancer.…

Articles about Sesen Bio's IPO: